ASCL1 and small cell lung carcinoma: This inactivation derepresses the neuroendocrine master regulator achaete-scute family bHLH transcription factor 1 (ASCL1), contributing to SCLC pathogenesis by maintaining the neuroendocrine phenotype and potentially enhancing cell survival (111).